← Back to Search

Other

Exercise trial for Connective Tissue

N/A
Waitlist Available
Led By Keith Baar, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 min post-exercise
Awards & highlights

Study Summary

The proposed study aims to shed light on the function/importance/relevance of exercise-induced changes in exosomes to connective tissues. Exosomes are known to increase robustly in response to exercise. We have previously shown that serum isolated from subjects after they lift heavy weights increases human engineered ligament collagen content and mechanics more than serum from before they lift weight. Further, we showed that exercise-induced changes in hormones could not explain the change in ligament structure or function. These data indicate that there is a significant gap in our understanding of muscle-connective tissue crosstalk. To address this gap, the current proposal seeks to: i) isolate and sequence exosomal RNA (long non-coding, miR, and mRNA) and ii) determine whether exosomes isolated from serum after exercise increase engineered ligament mechanics and collagen content.

Eligible Conditions
  • Connective Tissue
  • Exosomes
  • Exercise

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 min post-exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 min post-exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ligaments
Secondary outcome measures
Exosomal RNA
Ligaments

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise trialExperimental Treatment1 Intervention
Participants will perform a bout of exercise. In addition, a baseline and post-exercise blood sample will be drawn.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Exercise
2017
Completed Phase 4
~880

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,979 Total Patients Enrolled
1 Trials studying Connective Tissue
20 Patients Enrolled for Connective Tissue
Keith Baar, PhDPrincipal InvestigatorUniversity of California, Davis
5 Previous Clinical Trials
122 Total Patients Enrolled
1 Trials studying Connective Tissue
20 Patients Enrolled for Connective Tissue

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this research initiative?

"This clinical study seeks 12 individuals, aged 18 to 35, with a history of exercise (>1y) and no underlying health conditions. Additionally, they must possess exosomes at the time of enrollment."

Answered by AI

Is the recruitment phase for this experiment still open?

"Clinicaltrials.gov data indicates that this research effort, first launched on November 7th 2022, is currently recruiting participants. The study was last updated on the same day as its initial posting."

Answered by AI

Are individuals below the age of 65 eligible to partake in this investigation?

"This trial has stipulated that participants must be between 18 and 35 years old."

Answered by AI

How many participants is this clinical trial accepting at its maximum capacity?

"Correct. Clinicaltrials.gov confirms that this medical experiment, which was initially posted on November 7th 2022, is actively recruiting participants. A total of 12 patients need to be found from a single research centre."

Answered by AI
~5 spots leftby Apr 2025